GERALD MCMAHON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Celldex Therapeutics, Inc.

Filing Date Source Excerpt
2017-04-28 Gerald McMahon became a director of Celldex in December 2016. The following table summarizes the annual compensation for our non-employee directors during 2016. Gerald McMahon Fees Earned or Paid in Cash $9,625 Option Awards $20,062 Total $29,687
2018-04-30 Gerald McMahon Age 63 Year First Became Director 2016 The following table summarizes the annual compensation for our non-employee directors during 2017. Gerald McMahon Fees Earned or Paid in Cash $45,000 Stock Awards $23,200 Option Awards $23,345 Total $91,545

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2012-11-19 Gerald McMahon(4) 95,800 * (4) Includes options to purchase 95,800 shares of common stock, which are exercisable on November 1, 2012 or within 60 days thereafter.
2016-10-03 Includes 85,981 shares Dr. McMahon has the right to acquire currently or within 60 days of September 15, 2016, upon the exercise of options.

Data sourced from SEC filings. Last updated: 2025-12-07